BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16086057)

  • 1. [Effects of low molecular weight heparin on vascular endothelial growth factor expression of early diabetic nephropathy].
    Gan LY; Yu ZY; Cai MS; Zhao HP; Li X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):382-5. PubMed ID: 16086057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
    Guo H; Gan L; Yu Z
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1327-9. PubMed ID: 16200729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ; Yang YB; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
    Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats.
    Hou N; Huang N; Han F; Zhao J; Liu X; Sun X
    Int Urol Nephrol; 2014 Oct; 46(10):2045-51. PubMed ID: 25118612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y; Gu Y; Ma J; Lin S
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
    Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
    J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride reduces microvessel density and expression of vascular endothelial growth factor in renal tissue of diabetic rats.
    Tian HL; Zhao CX; Wu HY; Xu ZX; Wei LS; Zhao RT; Jin DL
    Am J Med Sci; 2015 Jun; 349(6):516-20. PubMed ID: 25789687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Volatile oil of Magnolia biondii inhibits expressions of P-selectin protein in serum and renal tissue of rats with diabetic nephropathy].
    Sun XP; Wang NS; Xue Q; Wang F
    Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):524-9. PubMed ID: 18471420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pioglitazone on diabetic nephropathy and expression of HIF-1α and VEGF in the renal tissues of type 2 diabetic rats.
    Xu X; Chen P; Zheng Q; Wang Y; Chen W
    Diabetes Res Clin Pract; 2011 Jul; 93(1):63-9. PubMed ID: 21514683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
    Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
    Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Shimojo N; Masuzawa K; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes.
    Yang QH; Liang Y; Xu Q; Zhang Y; Xiao L; Si LY
    Phytomedicine; 2011 Oct; 18(13):1148-52. PubMed ID: 21665452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
    J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
    Wang F; Li M; Cheng L; Zhang T; Hu J; Cao M; Zhao J; Guo R; Gao L; Zhang X
    Life Sci; 2008 Dec; 83(25-26):828-35. PubMed ID: 18983856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats.
    Kanter M; Sen S; Donmez S; Aktas C; Ustundag S; Erboga M
    Ren Fail; 2010 May; 32(4):498-505. PubMed ID: 20446791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
    Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
    J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.